Acadia Pharmaceuticals (ACAD) will replace Independent Bank Group (IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals appoints Thomas Garner Chief Commercial Officer
- Biotech Alert: Searches spiking for these stocks today
- Acadia announces exclusive license agreement with Saniona for SAN711
- Acadia Pharmaceuticals Announces Leadership Change Amid COO Departure
- Acadia Pharmaceuticals price target lowered to $32 from $33 at Canaccord